Pulmonary arterial hypertension is a severe disease with a poor prognosis despite available treatment options. Current recommendations support the use of a combination of therapies that target the endothelin, nitric-oxide, and prostacyclin pathways. Despite the benefits of intravenous prostacyclin…
from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader http://ift.tt/1QNGdQG
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1m7lURu
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1NDTKX7
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου